Skip to main content

Spinal Fusion

0
Pipeline Programs
8
Companies
10
Clinical Trials
4 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

T-Therapeutics
T-TherapeuticsUK - Cambridge
1 program
Auricular vagus nerve stimulationN/A1 trial
Active Trials
NCT07218133RecruitingEst. Dec 2026
SynerFuse
SynerFuseMN - Eden Prairie
1 program
DRG Neurostimulation with Spinal FusionN/A1 trial
Active Trials
NCT04054401Unknown20Est. Oct 2024
Kuros Biosciences
Kuros BiosciencesSwitzerland - Schlieren
1 program
Instrumented posterolateral spinal fusionN/A1 trial
Active Trials
NCT03625544Completed100Est. Oct 2024
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Laser Diode BraceN/A1 trial
Active Trials
NCT06282770Recruiting80Est. Jul 2026
Artoss
ArtossMN - St. Cloud
1 program
NanoBoneN/A4 trials
Active Trials
NCT06256458Recruiting200Est. Dec 2026
NCT04615260Active Not Recruiting40Est. Apr 2025
NCT04439032Active Not Recruiting330Est. Jun 2025
+1 more trials
SI-BONE
SI-BONESANTA CLARA, CA
1 program
iFuse Bedrock Granite Implant SystemN/A1 trial
Active Trials
NCT05640908Active Not Recruiting200Est. Dec 2027
Spine BioPharma
Spine BioPharmaNY - New York
1 program
long-segment posterior TL instrumented fusionN/A1 trial
Active Trials
NCT06368245Recruiting1,244Est. Jul 2029

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
T-TherapeuticsAuricular vagus nerve stimulation
Spine BioPharmalong-segment posterior TL instrumented fusion
ArtossNanoBone
Angeles TherapeuticsLaser Diode Brace
SI-BONEiFuse Bedrock Granite Implant System
SynerFuseDRG Neurostimulation with Spinal Fusion
ArtossNanoBone
ArtossNanoBone
ArtossNanoBone
Kuros BiosciencesInstrumented posterolateral spinal fusion

Clinical Trials (10)

Total enrollment: 2,414 patients across 10 trials

NCT07218133T-TherapeuticsAuricular vagus nerve stimulation

Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

Start: Oct 2025Est. completion: Dec 2026
N/ARecruiting
NCT06368245Spine BioPharmalong-segment posterior TL instrumented fusion

Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions

Start: Mar 2025Est. completion: Jul 20291,244 patients
N/ARecruiting
NCT06256458ArtossNanoBone

Prospective Registry to Evaluate Outcomes of NanoBone® Bone Graft in Acute Trauma

Start: Dec 2023Est. completion: Dec 2026200 patients
N/ARecruiting
NCT06282770Angeles TherapeuticsLaser Diode Brace

Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery

Start: Jul 2023Est. completion: Jul 202680 patients
N/ARecruiting
NCT05640908SI-BONEiFuse Bedrock Granite Implant System

Pelvic Fixation and Fusion During Multilevel Spinal Surgery

Start: Jun 2023Est. completion: Dec 2027200 patients
N/AActive Not Recruiting
NCT04054401SynerFuseDRG Neurostimulation with Spinal Fusion

SynerFuse Spinal Fusion and Neuromodulation Proof of Concept Study

Start: Jan 2022Est. completion: Oct 202420 patients
N/AUnknown
NCT04615260ArtossNanoBone

Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.

Start: Jul 2021Est. completion: Apr 202540 patients
N/AActive Not Recruiting
NCT04439032ArtossNanoBone

Artoss Prospective Spine Registry Outcomes

Start: Aug 2020Est. completion: Jun 2025330 patients
N/AActive Not Recruiting
NCT04503759ArtossNanoBone

Artoss Foot and Ankle Surgery Registry

Start: Aug 2020Est. completion: May 2024200 patients
N/ACompleted
NCT03625544Kuros BiosciencesInstrumented posterolateral spinal fusion

MagnetOs™ Granules vs. Autograft in Instrumented Posterolateral Spinal Fusion

Start: Jul 2018Est. completion: Oct 2024100 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 actively recruiting trials targeting 2,414 patients
8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.